glp 1 in obesity Targeting GLP-1, GIP & GCG and Type 2 Diabetes Research The effect of GLP-1R agonists
Description
These treatments may become valuable tools for maintaining cognitive health while addressing metabolic concerns
While GLP-1 medications themselves are approved at specific doses for diabetes and obesity, using smaller, extended or maintenance doses has not been formally studied
Theyre helping people sleep better, lower their blood pressure, reduce their risk of stroke, and shed weight in ways that had previously felt impossible
Molecular Metabolism, 46, 101102
doi: 10.1038/s41598-019-55524-w
